The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Intel Corporation have announced a collaboration aimed at improving research and treatment for Parkinson’s disease.
The collaboration includes a multiphase research study using a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms. This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in drug development.
Todd Sherer, PhD, CEO of The Michael J. Fox Foundation said: “Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.”
“The variability in Parkinson’s symptoms creates unique challenges in monitoring progression of the disease,” said Diane Bryant, senior vice president and general manager of Intel’s Data Center Group. “Emerging technologies can not only create a new paradigm for measurement of Parkinson’s, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research.”
Funding will help to address critical humanitarian problems around the world
Tech for Good programme invites applications to help more charities achieve social change through technology
Colleagues at Shop Direct have raised £210,000 in just 12 months to support the development of a new digital app for Alder Hey Children’s Hospital
New digital investment service for charities will provide access to the biggest selection of charity-specific investment funds